Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPL | P05186 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ALPG | P10696 | 1/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.31 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL3684537 | 0.88 | ALPL (0.37) | ALPLPOLBALPG | |
| SCHEMBL3681360 | 0.87 | ALPL (0.38) | ALPLPOLBALPG | |
| Hydrochloric Acid SCHEMBL6045267 | 0.84 | ALPL (0.36) | ALPLPOLBALPG | |
| Acetic Acid SCHEMBL3682289 | 0.82 | ALPL (0.35) | ALPLPOLBALPG | |
| Acetic Acid SCHEMBL3682298 | 0.78 | ALPL (0.41) | ALPLPOLBALPG | |
| Trifluoroacetic Acid SCHEMBL27637911 | 0.71 | DPP8 (0.40) | DPP8DPP7DPP4 | |
| Trifluoroacetic Acid SCHEMBL27408382 | 0.71 | CA2 (0.52) | — | |
| Trifluoroacetic Acid SCHEMBL12230978 | 0.71 | ALDH1A1 (0.39) | — | |
| Trifluoroacetic Acid SCHEMBL31031817 | 0.71 | FAAH (0.42) | POLB | |
| Trifluoroacetic Acid SCHEMBL27841664 | 0.71 | FAAH (0.42) | POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8410150-B2 | Inhibitors of carnitine palmitoyltransferase and treating cancer | UNIVERSITY HEALTH NETWORK (CA) | 2013-04-02 | — | — | US | disclosed |
| US-20100105900-A1 | INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER | UNIVERSITY HEALTH NETWORK | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105900-A1 | INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER | CPT1A, CPT1B, CPT2 | ALPL 2487/4885POLB 1534/4885ALPG 4032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.